These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 1825747)

  • 1. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
    Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vasodilator responses to RP 52891 are mediated by activation of a glibenclamide-sensitive K+ATP channel.
    Hood JS; McMahon TJ; Kadowitz PJ
    Eur J Pharmacol; 1991 Sep; 202(1):121-4. PubMed ID: 1786798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized rats.
    Smits GJ; Perrone MH; Cox BF
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):49-56. PubMed ID: 9007670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
    Yanagisawa T; Teshigawara T; Taira N
    Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of lemakalim on the pulmonary vascular bed of the cat.
    Hood JS; McMahon TJ; Kadowitz PJ
    Eur J Pharmacol; 1991 Sep; 202(1):101-4. PubMed ID: 1786796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.
    Yanagisawa T; Hashimoto H; Taira N
    Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle.
    Satoh E; Yanagisawa T; Taira N
    Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
    Garrino MG; Plant TD; Henquin JC
    Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state.
    Seki S; Sato K; Nakayama M; Murray PA
    Anesthesiology; 1997 Apr; 86(4):923-35. PubMed ID: 9105237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil.
    Longman SD; Clapham JC; Wilson C; Hamilton TC
    J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
    D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG
    Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells.
    Allard B; Lazdunski M
    Eur J Pharmacol; 1993 Jun; 236(3):419-26. PubMed ID: 8359200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
    Yoneyama F; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative electrophysiological and mechanical actions of ATP-sensitive potassium channel openers in canine Purkinje fibers.
    Satoh H
    Gen Pharmacol; 1993 May; 24(3):565-75. PubMed ID: 8365637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of responses to sarafotoxins 6a and 6c in pulmonary and systemic vascular beds.
    Minkes RK; Bellan JA; Higuera TR; Kadowitz PJ
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H852-61. PubMed ID: 1348398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the vasodepressor response to adenosine by nicorandil in rats: comparison with cromakalim.
    Saito K; Sakai K
    Fundam Clin Pharmacol; 1998; 12(1):37-43. PubMed ID: 9523182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model].
    Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y
    Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
    Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC
    Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.